De-Risking Cell & Gene Therapy Workflows: Exploring Downstream Processes
Exploring downstream processes with class-defining solutions for bioproduction workflows.

In the manufacturing and distributing of cell and gene therapies, ensuring smooth and sustainable workflow processing is essential for identifying and addressing potential issues. Achieving optimal culture conditions, ensuring quality, and maintaining consistency throughout the development process are key factors in preventing unforeseen outcomes that could jeopardize the final product.

Delve into the downstream process with this eBook, focusing on reducing risks in workflows for cell and gene therapy, and explore solutions that define the class of bioproduction workflows. Gain exclusive insights from key figures in the bioproduction space, including Sean Werner from Biolife Solutions and Erik Woods, Co-Founder, Chief Scientific Officer, and EVP of Ossium Health.

Join us on this exploration of defining solutions for optimizing bioproduction workflows